PIANTONI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.968
EU - Europa 1.080
AS - Asia 968
SA - Sud America 204
AF - Africa 24
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.251
Nazione #
US - Stati Uniti d'America 1.930
SG - Singapore 396
CN - Cina 253
DE - Germania 213
IT - Italia 200
BR - Brasile 182
PL - Polonia 137
HK - Hong Kong 136
FI - Finlandia 119
UA - Ucraina 94
GB - Regno Unito 78
RU - Federazione Russa 59
VN - Vietnam 49
FR - Francia 40
TR - Turchia 37
SE - Svezia 32
IE - Irlanda 31
CA - Canada 22
NL - Olanda 19
BD - Bangladesh 17
IN - India 16
JP - Giappone 10
ZA - Sudafrica 10
AT - Austria 9
IQ - Iraq 9
MX - Messico 9
AR - Argentina 8
ES - Italia 8
MK - Macedonia 7
BE - Belgio 6
GR - Grecia 6
ID - Indonesia 6
KR - Corea 6
CZ - Repubblica Ceca 5
AU - Australia 4
EG - Egitto 4
KE - Kenya 4
MA - Marocco 4
PK - Pakistan 4
PT - Portogallo 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CH - Svizzera 3
CO - Colombia 3
JO - Giordania 3
LT - Lituania 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
EC - Ecuador 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
NI - Nicaragua 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.251
Città #
Ashburn 261
Fairfield 222
Singapore 191
Hong Kong 134
Warsaw 134
Woodbridge 118
Chandler 91
Seattle 89
Houston 88
Cambridge 84
New York 82
Beijing 80
Helsinki 79
Jacksonville 79
Wilmington 76
Dallas 69
Munich 63
Princeton 58
Ann Arbor 44
Los Angeles 38
Brescia 34
Turku 33
Dublin 31
Istanbul 30
São Paulo 23
Milan 20
San Francisco 20
Redondo Beach 19
Buffalo 18
The Dalles 18
Moscow 16
Des Moines 15
Hanoi 14
Ho Chi Minh City 14
London 14
San Diego 13
Shanghai 13
Bergamo 12
Nanjing 12
Chicago 10
Denver 10
Santa Clara 10
Johannesburg 9
Brooklyn 8
Changsha 8
Nanchang 8
Nuremberg 8
Salò 8
Stockholm 8
Tokyo 8
Vienna 7
Belo Horizonte 6
Boardman 6
Brussels 6
Ferrara 6
Montreal 6
Shenyang 6
Vancouver 6
Albuquerque 5
Amsterdam 5
Atlanta 5
Chennai 5
Dhaka 5
Frankfurt am Main 5
Haikou 5
Jiaxing 5
Ningbo 5
Nürnberg 5
Orem 5
Rio de Janeiro 5
Bosio 4
Cairo 4
Council Bluffs 4
Dong Ket 4
Dosso 4
Guangzhou 4
Hebei 4
Jakarta 4
Jinan 4
Lappeenranta 4
Nairobi 4
Olomouc 4
Redwood City 4
Rivoli 4
Rome 4
Seoul 4
State College 4
Amman 3
Baghdad 3
Baku 3
Bogotá 3
Campinas 3
Columbus 3
Duncan 3
Erbil 3
Falkenstein 3
Mariano Comense 3
Mexico City 3
Miami 3
New Bedfont 3
Totale 2.760
Nome #
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 318
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 177
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 174
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 173
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 168
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 167
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 158
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 153
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 152
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 146
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 145
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 143
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 139
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 133
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 128
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 124
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 121
Pathophysiological role and therapeutic implications of vitamin d in autoimmunity: Focus on chronic autoimmune diseases 114
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 102
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 101
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 97
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 93
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis 89
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 87
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 84
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 79
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 76
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 75
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 66
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 64
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada 61
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 59
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 59
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 55
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 55
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 52
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases 50
Editorial: Into the heart of systemic autoimmune diseases. 49
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 45
Totale 4.331
Categoria #
all - tutte 23.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021319 0 0 0 0 0 57 30 44 45 73 36 34
2021/2022321 26 24 9 29 3 26 14 17 15 51 44 63
2022/2023250 33 8 7 19 27 62 3 28 46 0 7 10
2023/2024419 23 11 57 44 22 82 12 63 60 6 2 37
2024/2025933 9 19 21 110 71 83 57 54 96 94 181 138
2025/20261.002 176 229 145 235 197 20 0 0 0 0 0 0
Totale 4.331